Vaccine compositions
US8226959B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2009 |
| Grant date | Jul 24, 2012 |
| Priority date | — |
| Expiry date | Feb 2, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods for the treatment or prevention of allergic airways diseases, the suppression of allergic immune responses, and the induction protective immunity against allergic airways diseases wherein the methods comprise administering to subjects in need thereof an effective amount of a Streptococcus pneumoniae capsular polysaccharide and a Streptococcus pneumoniae exotoxin or exotoxoid, optionally together with one or more additional antigenic or immunomodulatory constituents, components or fractions of Streptococcus pneumoniae and/or immunopotentiators. Administration of individual components is also contemplated. Also provided are vaccine compositions suitable for use in accordance with methods disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.